<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Albireo Pharma, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Albireo Pharma, Inc.

    Albireo is a clinical-stage biopharmaceutical company focused on the development and potential commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. We have deep expertise in bile acid biology and a pipeline of clinical and nonclinical programs. Our parent company, Albireo Pharma, Inc., is located in Boston, Massachusetts and our key operating subsidiary, Albireo AB, is located in Gothenburg, Sweden. We were spun out from AstraZeneca in 2008. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Ron Cooper
    • FOUNDED
      2003
    • EMPLOYEES
      20
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Bionano Genomics, Inc.

    Bionano Genomics, Inc.

    Bionano is a life sciences instrumentation company in the genome analysis space. B...

    Bionano is a life sciences instrumentation comp...

    Filing Type:    PU
    Harvard Bioscience, Inc.

    Harvard Bioscience, Inc.

    Harvard Bioscience is a global developer, manufacturer and marketer of a broad ran...

    Harvard Bioscience is a global developer, manuf...

    Filing Type:    PU
    Insulet Corporation

    Insulet Corporation

    Insulet Corporation is an innovative medical device company based in Acton, Massac...

    Insulet Corporation is an innovative medical de...

    Filing Type:    PU
    Incyte Corporation

    Incyte Corporation

    Incyte Corporation is a Wilmington, Delaware-based biopharmaceutical company focus...

    Incyte Corporation is a Wilmington, Delaware-ba...

    Filing Type:    PU
    Chimerix, Inc.

    Chimerix, Inc.

    Chimerix is a development-stage biopharmaceutical company dedicated to acceleratin...

    Chimerix is a development-stage biopharmaceutic...

    Filing Type:    PU
    Vir Biotechnology, Inc.

    Vir Biotechnology, Inc.

    Vir integrates diverse innovations in science, technology, and medicine to transfo...

    Vir integrates diverse innovations in science, ...

    Filing Type:    PU
    Mirum Pharmaceuticals, Inc.

    Mirum Pharmaceuticals, Inc.

    Mirum Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company focused o...

    Mirum Pharmaceuticals Inc. is a clinical-stage ...

    Filing Type:    PU
    Intercept Pharmaceuticals, Inc.

    Intercept Pharmaceuticals, Inc.

    Intercept is a biopharmaceutical company focused on the development and commercial...

    Intercept is a biopharmaceutical company focuse...

    Filing Type:    PU
    Hepion Pharmaceuticals, Inc.

    Hepion Pharmaceuticals, Inc.

    Hepion Pharmaceuticals (Nasdaq: HEPA) is a clinical stage biopharmaceutical compan...

    Hepion Pharmaceuticals (Nasdaq: HEPA) is a clin...

    Filing Type:    PU
    Ironwood Pharmaceuticals, Inc.

    Ironwood Pharmaceuticals, Inc.

    Ironwood Pharmaceuticals (Nasdaq: IRWD) is a GI-focused healthcare company dedicat...

    Ironwood Pharmaceuticals (Nasdaq: IRWD) is a GI...

    Filing Type:    PU
    Seres Therapeutics, Inc.

    Seres Therapeutics, Inc.

    Seres Therapeutics, Inc. is a microbiome therapeutics platform company developing ...

    Seres Therapeutics, Inc. is a microbiome therap...

    Filing Type:    PU
    Redhill Biopharma Ltd.

    Redhill Biopharma Ltd.

    RedHill Biopharma Ltd. (NASDAQ: RDHL) (Tel-Aviv Stock Exchange: RDHL) is a special...

    RedHill Biopharma Ltd. (NASDAQ: RDHL) (Tel-Aviv...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.